288 related articles for article (PubMed ID: 16341572)
21. Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses.
Morrow DI; McCarron PA; Woolfson AD; Juzenas P; Juzeniene A; Iani V; Moan J; Donnelly RF
J Pharm Sci; 2010 Aug; 99(8):3486-98. PubMed ID: 20222026
[TBL] [Abstract][Full Text] [Related]
22. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
23. Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias.
McCarron PA; Donnelly RF; Woolfson AD
Pharm Res; 2008 Apr; 25(4):812-26. PubMed ID: 17657596
[TBL] [Abstract][Full Text] [Related]
24. Epidermal penetration and protoporphyrin IX formation of two different 5-aminolevulinic acid formulations in ex vivo human skin.
Schmitz L; Novak B; Hoeh AK; Luebbert H; Dirschka T
Photodiagnosis Photodyn Ther; 2016 Jun; 14():40-6. PubMed ID: 26607556
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model.
Maisch T; Santarelli F; Schreml S; Babilas P; Szeimies RM
Exp Dermatol; 2010 Aug; 19(8):e302-5. PubMed ID: 19845760
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.
Fang YP; Tsai YH; Wu PC; Huang YB
Int J Pharm; 2008 May; 356(1-2):144-52. PubMed ID: 18325699
[TBL] [Abstract][Full Text] [Related]
27. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
28. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
[TBL] [Abstract][Full Text] [Related]
29. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy.
Donnelly RF; McCarron PA; Woolfson AD
Photochem Photobiol; 2005; 81(4):750-67. PubMed ID: 15790300
[TBL] [Abstract][Full Text] [Related]
30. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
31. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
Forster B; Klein A; Szeimies RM; Maisch T
Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
[TBL] [Abstract][Full Text] [Related]
32. Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles.
Donnelly RF; McCarron PA; Al-Kassas R; Juzeniene A; Juzenas P; Iani V; Woolfson AD; Moan J
Biopharm Drug Dispos; 2009 Mar; 30(2):55-70. PubMed ID: 19226650
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
Mizutani K; Watanabe D; Akita Y; Akimoto M; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):280-2. PubMed ID: 19747250
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
35. A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy.
Rossetti FC; Lopes LB; Carollo AR; Thomazini JA; Tedesco AC; Bentley MV
J Control Release; 2011 Nov; 155(3):400-8. PubMed ID: 21763732
[TBL] [Abstract][Full Text] [Related]
36. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model.
Juzeniene A; Juzenas P; Iani V; Moan J
Photochem Photobiol; 2002 Sep; 76(3):329-34. PubMed ID: 12403455
[TBL] [Abstract][Full Text] [Related]
37. A Formulation Study of 5-Aminolevulinic Encapsulated in DPPC Liposomes in Melanoma Treatment.
Lin MW; Huang YB; Chen CL; Wu PC; Chou CY; Wu PC; Hung SY
Int J Med Sci; 2016; 13(7):483-9. PubMed ID: 27429584
[TBL] [Abstract][Full Text] [Related]
38. Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy.
Araújo LM; Thomazine JA; Lopez RF
Eur J Pharm Biopharm; 2010 May; 75(1):48-55. PubMed ID: 20083197
[TBL] [Abstract][Full Text] [Related]
39. Novel patch-based systems for the localised delivery of ALA-esters.
Morrow DI; McCarron PA; Woolfson AD; Juzenas P; Juzeniene A; Iani V; Moan J; Donnelly RF
J Photochem Photobiol B; 2010 Oct; 101(1):59-69. PubMed ID: 20634088
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models.
Fujita AK; Rodrigues PG; Requena MB; Escobar A; da Rocha RW; Nardi AB; Kurachi C; de Menezes PF; Bagnato VS
Photodiagnosis Photodyn Ther; 2016 Sep; 15():236-44. PubMed ID: 27288253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]